WW International, Inc. (WW) stock has shown a remarkable performance in the past three months, outpacing the S&P 500 and the industry. In the same time frame, WW has surged 66.8% compared with the industry’s 31.7% rally and the S&P 500’s 9.2% rise.On Monday, the stock closed at $1.28, significantly below its 52-week high of $9.77 but above its 52-week low of 67 cents. Over the past three months, WW has outpaced industry peer The Beachbody Company, Inc.’s (BODI) 4.4% decline, Planet Fitness, Inc.’s (PLNT) 26 ...

NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced the appointment of Felicia DellaFortuna as Chief Financial Officer, effective January 1, 2025. She succeeds Heather Stark, who will remain with the Company through December 27, 2024. “We are thrilled to welcome Felicia DellaFortuna as our new Chief Financial Officer at this pivotal time for WeightWatchers,” said Tara Comonte, Interim Chief Executive Officer. “Felicia bri ...

WW International (WW) has been on a downward spiral lately with significant selling pressure. After declining 26.7% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.How to Determine if a Stock is OversoldWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a ...

Financial Data and Key Metrics Changes - The company ended Q3 2024 with 3.7 million subscribers, a decline of 9% year-over-year, reflecting recruitment challenges due to increased consumer acquisition costs [46] - Revenue totaled $193 million, with subscription revenues at $191 million, down 6% year-over-year [47] - Adjusted gross margin reached a record high of 69.1%, up from 66.2% in the prior year [49] - Adjusted operating income was $36 million, reflecting an operating margin of 18.5%, a year-on-year increase of almost 150 basis points [53] Business Line Data and Key Metrics Changes - Clinical subscribers grew to 78,000, representing a 71% increase compared to the prior year, contributing an additional $9 million in subscription revenue [48] - Digital and workshops revenue declined due to lower sign-ups and a shift from workshops to digital subscriptions [47] Market Data and Key Metrics Changes - The company noted that competition has driven a significant increase in customer acquisition costs, which rose approximately 30% year-on-year [50][94] - The clinical business is experiencing increased demand, with predictions that up to 30 million people in the U.S. may be using GLP-1s by 2030 [24] Company Strategy and Development Direction - The company aims to simplify and integrate its digital experience, enhancing member engagement across its weight management solutions [38] - A brand refresh is underway to improve market awareness and engagement, focusing on community and livability [21][74] - The company is committed to leveraging its scientific research and community support to enhance its offerings in the evolving healthcare landscape [14][16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about future growth despite current challenges, emphasizing the importance of adapting to the evolving weight management industry [9][12] - The company is focused on improving member retention and addressing cost and access issues that contribute to subscriber churn [76] Other Important Information - The company is on track to achieve $100 million in cost savings by the end of 2025, with significant reductions in adjusted G&A expenses [52] - Cash flow from operations improved, reverting to positive in Q3 2024, with expectations for modest cash use for the full year [59] Q&A Session Summary Question: Thoughts on the compounding launch and its impact on LTV to CAC - Management noted a positive impact on sign-ups and CAC following the compounding launch, with the highest sign-up day in 2024 [66][67] Question: Retention on the clinical side and reasons for churn - Management indicated that cost and access are the primary reasons for clinical subscriber churn, with recent improvements in member experience positively impacting retention [76][77] Question: Investment needed for rebranding and cost savings - Management acknowledged that some investment will be required for rebranding while focusing on profitability and liquidity [80][84] Question: Changes in consumer acquisition costs and competitive market - Management observed early relief in acquisition costs but noted that they remain elevated due to competition and media inflation [85][94] Question: Confidence in employer demand for weight loss solutions - Management expressed optimism that employers will increasingly need to offer weight loss solutions, positioning the company well in this evolving market [90][91]

WW International (WW) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 380%. A quarter ago, it was expected that this weight-loss program operator would post earnings of $0.03 per share when it actually produced a loss of $0.13, delivering a surprise of -533.33%.Over the last four quar ...

Subscriber Metrics - End of Period Subscribers decreased by 8.8% year-over-year to 3.7 million, with a notable increase of 71.5% in Clinical Subscribers to 78,000[4] - Total end of period subscribers decreased to 3,667 in September 2024, down 8.8% from 4,022 in September 2023[25] - Digital subscribers at the end of the period were 3,043, a decline of 7.3% from 3,284 in the previous year[25] - Clinical subscribers increased significantly by 71.5% to 78 in September 2024, compared to 45 in September 2023[25] Revenue Performance - Revenues for Q3 2024 were $192.9 million, reflecting a 10.2% decline compared to the prior year, with Subscription Revenues at $191.2 million, down 6.0%[3] - Total revenues for the three months ended September 28, 2024, were $192,887, a decrease of 10.2% compared to $214,871 for the same period last year[18] - Subscription revenues for the three months ended September 28, 2024, were $191,248, down 6.3% from $203,496 in the same period last year[18] - Year-to-date total revenues for 2024 were $601,508, down 12.0% from $683,594 in 2023[27] - Year-to-date digital subscription revenues were $399,364, a decrease of 8.7% from $437,613 in 2023[27] - Other revenues plummeted 89.0% to $6,248 in 2024, compared to $56,927 in 2023[27] Profitability and Loss - Operating Loss for Q3 2024 was $39.0 million, compared to an Operating Income of $30.6 million in the prior year, with Adjusted Operating Income at $35.7 million[5] - Net Loss for Q3 2024 was $46.2 million, compared to a Net Income of $43.7 million in the prior year, resulting in a Diluted Net Loss per share of $0.58[5] - Operating loss for the three months ended September 28, 2024, was $(39,045), a significant decline from operating income of $30,607 in the same period last year[18] - Net loss for the three months ended September 28, 2024, was $(46,192), compared to a net income of $43,731 in the same period last year[18] - The company experienced a 205.6% increase in net loss compared to the previous year[28] - Net Loss for YTD 2024 was $(370,824), representing an increase of 1,438.8% compared to a net loss of $(24,120) in YTD 2023[29] - Diluted Net Loss Per Share for YTD 2024 was $(4.67), compared to $(0.32) in YTD 2023, marking an increase of 1,368.8%[29] Margins and Expenses - Gross Margin improved to 67.1%, up from 66.0% in the prior year, while Adjusted Gross Margin increased to 69.1% from 66.2%[4] - Gross Profit for Q3 2024 was $129,496 thousand, with a gross margin of 67.1%[28] - Adjusted gross profit increased to $133,316 thousand, reflecting a gross margin of 69.1%[28] - Selling, general and administrative expenses totaled $67,094 thousand, with an adjusted figure of $53,250 thousand[28] - Selling, General and Administrative Expenses decreased by 8.0% to $154,534 in YTD 2024 from $168,423 in YTD 2023[29] Cash and Assets - Cash balance as of September 28, 2024, was $57.2 million, with no outstanding borrowings under its revolving credit facility[6] - Total current assets decreased from $179,474 million on December 30, 2023, to $101,228 million on September 28, 2024, a decline of approximately 43.5%[17] - Cash and cash equivalents dropped from $109,366 million to $57,181 million, representing a decrease of about 47.8%[17] Impairments and Charges - The company reported an impairment of franchise rights acquired amounting to $315,033 for the nine months ended September 28, 2024[21] - The company reported a significant impairment charge of $54,295 thousand related to franchise rights acquired[28] - The company incurred impairment charges of $315 million related to franchise rights acquired in the first nine months of fiscal 2024[35] Guidance and Future Outlook - The Company is reiterating its full year fiscal 2024 guidance of at least 3.1 million total subscribers and revenues of at least $770.0 million[7] - Adjusted Operating Income guidance for fiscal 2024 is set at a minimum of $100.0 million, excluding certain charges[7] - Forward-looking statements indicate potential risks related to competition and market dynamics in the weight management sector[15] - Future outlook includes ongoing restructuring efforts with associated charges impacting financial performance[28]

NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the third quarter 2024 before market open on Wednesday, November 6, 2024. WeightWatchers will host a conference call at 8:30 a.m. ET the same day. During the conference call, Tara Comonte, Interim President and Chief Executive Officer, and Heather Stark, Chief Financial Officer, will discuss the third quarter 2024 results and answer questions from the invest ...

Shares of WW International Inc (WW, Financial) soared by 43.09% today due to the company's strategic move to expand its clinical weight management services. This expansion includes the introduction of compounded semaglutide, which offers a cost-effective and accessible alternative to popular medications like Ozempic and Wegovy, particularly during the current supply shortages. WW International Inc, trading under the ticker WW, is currently priced at $1.66. Despite the recent surge, the company's stock had e ...

WW International (WW, Financial) experienced a significant stock price increase, soaring 20.7% to $1.40. Early trading saw the stock rise as much as 46.5%. The surge follows the company's announcement to integrate compounded semaglutide, starting at $129, into its weight loss solutions. This addition broadens access for eligible members to clinical weight management interventions, which are grounded in comprehensive and scientifically backed behavioral and lifestyle support. ...

Group 1 - WW International experienced a significant stock movement, initially surging over 46.5% before stabilizing at around a 25% increase, reaching $1.45 [1] - The stock's movement was influenced by the company's announcement to incorporate compounded semaglutide into its weight loss programs, starting at $129 [2] - This new addition aims to expand access for eligible members to clinical weight loss interventions, supported by comprehensive scientific behavior and lifestyle support [2]